Key result
Hereditary warfarin resistance requires ~4-fold normal plasma levels to achieve adequate anticoagulation.
Why the study?
Hereditary resistance to warfarin is rare and not well characterized, with few families reported.
Case Report (n=2)
This case report describes the third known family with hereditary warfarin resistance, demonstrating that the resistance is due to altered pharmacodynamics requiring significantly higher doses for therapeutic anticoagulation.
Answers are grounded in this paper and cite their sources.
Hereditary warfarin resistance may require extreme dosing; extends sparse case reports to a third family with pharmacodynamic alteration.
A 57-year-old black woman required a daily dosage of 50 mg of warfarin sodium to maintain her prothrombin time in a therapeutic range. The central volume of distribution and clearance of warfarin were normal for this patient. These findings, combined with the patient's requirement for plasma warfarin levels four times greater than those usually required to achieve adequate anticoagulation, indicated that the relative resistance was due to altered pharmacodynamics of warfarin. The only child of the propositus, a daughter, showed a similar relative resistance, confirming that this family is the third to be reported with hereditary resistance to warfarin.
No takes yet. Share an insight, caveat, or question.
Barbara M. Alving (1985) conducted a case report in Hereditary Warfarin Resistance (n=2). Warfarin sodium was evaluated on Prothrombin time in a therapeutic range. A 57-year-old woman and her daughter exhibited hereditary warfarin resistance, requiring a daily dosage of and plasma levels four times normal to achieve adequate anticoagulation.
Synapse has enriched 10 related papers. Consider them for comparative context: